Almirall SA, of Barcelona, Spain, and Forest Laboratories Inc., of New York, reported positive topline results from AUGMENT COPD, the second six-month pivotal Phase III trial evaluating the efficacy and safety of investigational fixed-dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA), delivered in the Pressair (Genuairn outside the U.S.) inhaler

Discovery Laboratories Inc., of Warrington, Pa., said two peer-reviewed journals published articles related to Afectair, the company's aerosol-conducting airway connector, which is designed with the goal of simplifying and improving aerosolized medication delivery to infants requiring mechanical ventilation in the neonatal and pediatric intensive care units

Impax Pharmaceuticals, of Hayward, Calif., a division of Impax Laboratories Inc., said their collaboration with GlaxoSmithKline plc (GSK) for the development and commercialization of Rytary (IPX066) outside the U.S

Almirall SA, of Barcelona, Spain, and Forest Laboratories Inc., of New York, reported top-line results from a six-month pivotal Phase III study testing fixed-dose combinations of aclidinium bromide, a long-acting muscarinic beta2 agonist, and formoterol fumarate, a long-acting beta2 agonist, delivered using Almirall's inhaler Genuair

Unigene Laboratories Inc., of Boonton, N.J., said Victory Park Capital Advisors (VPC) held a public auction for the sale of certain assets that secure about $56.7 million in senior secured notes issued to affiliates of VPC by Unigene

Charleston Laboratories Inc., of Charleston, S.C., said the FDA granted its request for a pre-investigational new drug application meeting to discuss CL-H1T as a treatment for patients who suffer from migraine pain and migraine-induced nausea or vomiting

Discovery Laboratories Inc., of Warrington, Pa., said the FDA requested clarification and provided recommendations regarding the recently updated product specifications for Surfaxin (lucinactant), and the company said it expects to provide a response to the agency within two months

Columbia Laboratories Inc., of Livingston, N.J., extended its Crinone (progesterone gel) license and supply agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, of Darmstadt, Germany, for five years, through May 2020

The funds had been held in escrow following the July 2012 sale of Welichem's development and commercialization rights to WBI-1001 outside the four territories to Stiefel Laboratories Inc., part of London-based GlaxoSmithKline plc (GSK

Unigene Laboratories Inc., of Boonton, N.J., said that the outcome of an FDA Advisory Committee Meeting on March 5 regarding calcitonin salmon for postmenopausal osteoporosis will have a materially adverse effect on its finances and operations

Columbia Laboratories Inc., of Livingston, N.J., said its board adopted an amendment to its stockholder rights plan, extending the expiration date of the rights plan to July 3, 2016...Impax Laboratories Inc., of Hayward, Calif., is being investigated by attorneys at Bronstein, Gewirtz & Grossman LLC on potential claims on behalf of purchasers of the company's securities

Immunotech Laboratories Inc., of Pasadena, Calif., said the firm relocated to a new R&D facility in Monrovia, Calif

Ipsen SA, of Paris, and Braintree Laboratories Inc., of Braintree, Mass., said that Eziclen/Izinova (BLI-800) completed the European decentralized registration procedure, giving member states 30 days to decide whether to grant marketing authorization

Shire plc, of Dublin, Ireland, said its Shire LLC subsidiary settled all pending litigation with Impax Laboratories Inc., of Hayward, Calif., over Shire's supply of an authorized generic version of Adderall XR (mixed amphetamine salts

Ipsen SA, of Paris, and Braintree Laboratories Inc., of Braintree, Mass., said that Eziclen/Izinova (BLI-800) completed the European decentralized registration procedure, giving member states 30 days to decide whether to grant marketing authorization

The company brought patent infringement action in April 2010 against generic firm Watson Laboratories Inc., of Parsippany, N.Y., (now known as Actavis) after Watson applied to the FDA to market a generic version of Rapamune

Auxilium Pharmaceuticals Inc., of Malvern, Pa., and Xstelos Holdings Inc., of New York, filed a lawsuit against Upsher-Smith Laboratories Inc., of San Diego, alleging infringement of 10 patents related to Testim 1 percent testosterone gel

Forest Laboratories Inc., of New York, said its Canadian subsidiary, Forest Laboratories Canada Inc., received a notice of compliance from Health Canada for Bystolic (nebivolol) tablets, a once-daily beta blocker for hypertension

MorphoSys AG, of Martinsried, Germany, said it completed the sale of research and diagnostic antibody division AbD Serotec to Bio-Rad Laboratories Inc., of Hercules, Calif., for about $70 million in cash